MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The EON (Elderly patients on ONgentys) study in Parkinson’s disease: design and rationale of a prospective non-interventional trial

    V. Dostal, K. Chaudhuri, P. Odin, M. Kurtis, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Norwich, United Kingdom)

    Objective: To assess the tolerability of opicapone (OPC) when used in elderly patients with Parkinson’s disease (PD) in real-world conditions. Background: OPC proved to be…
  • MDS Virtual Congress 2021

    Survey-Based study of marijuana used in Parkinson’s Disease patients

    R. Healy, J. Paulson, A. Deb, K. Smith (Worcester, USA)

    Objective: A survey based assessment of marijuana use in patients with Parkinson’s disease. Background: Due to marijuana’s controlled status little quality research and no clear…
  • MDS Virtual Congress 2021

    Opicapone in Clinical Practice in Parkinson’s Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

    A. Lees, H. Reichmann, D. Magalhães, J. Rocha, P. Soares-da-Silva (London, United Kingdom)

    Objective: To evaluate opicapone (OPC) when used in everyday clinical practice conditions to treat Parkinson’s disease (PD) patients with motor fluctuations. Background: OPC proved to…
  • MDS Virtual Congress 2021

    Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation: Final results from PROviDE study

    R. Pahwa, S. Isaacson, R. Dorsey, D. Cella, B. Bluett, S. Thakkar, P. Kandukuri, N. Gupta, Y. Jalundhwala, Y. Bao, I. Pan, O. Ladhani, J. Aldred (Kansas City, USA)

    Objective: To examine the real-world long-term effectiveness of carbidopa/levodopa enteral suspension (CLES) on off time and other patient reported outcomes (PROs) among advanced Parkinson’s disease…
  • MDS Virtual Congress 2021

    The effectiveness of home modification on gait and falling episode in Parkinson’s disease (PD) patients.

    J. Sringean, S. Phumphid, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: Identify the unsafe PD patients’ home who had gait problems and provide home modifications. Background: The motor impairments in PD also involve both appendicular…
  • MDS Virtual Congress 2021

    Improved Excessive Daytime Sleepiness with Selegiline in patients with Parkinson’s Disease: An Open Trial

    JR. Zhang, JP. Chen, J. Li, J. Li, CJ. Mao, CF. Liu (Suzhou, China)

    Objective: This study, an open-labeled trial, was aimed to assess the efficacy and safety of selegiline on the treatment of EDS in PD patients. Background: Excessive Daytime…
  • MDS Virtual Congress 2021

    Oligodendroglial-derived exosomes as mediators of α-synuclein pathology in MSA-like models

    M. Vetsi, G. Tsaka, P. Mavroeidi, F. Arvanitaki, M. Zweckstetter, S. Becker, PH. Jensen, L. Stefanis, M. Xilouri (Athens, Greece)

    Objective: The current study focuses in elucidating the contribution of oligodendroglial-derived exosomes in the development and spread of α-Synuclein (αSyn) pathology in Multiple System Atrophy…
  • MDS Virtual Congress 2021

    The loss of skeletal muscle mass in progressive supranuclear palsy

    Y. Takamatsu, I. Aiba (Sapporo, Japan)

    Objective: To investigate body composition parameters, focusing on skeletal muscle mass, in patients with progressive supranuclear palsy (PSP) and compared them with those of healthy…
  • MDS Virtual Congress 2021

    SARS CoV2 in older patients with Parkinson’s.

    M. Khwaja, T. Nanayakkara, G. Pun, M. Todd, A. Chatterjee, N. Butt, N. Virgincar (Reading, United Kingdom)

    Objective: To review the clinical presentation and management of SARS-CoV 2 in older patients with Parkinson’s during the first wave of the pandemic in West…
  • MDS Virtual Congress 2021

    Determinants of exercise behavior in Parkinson’s disease patients: Self-confidence in balance and fatigue play the pivotal role.

    J. Song, WY. Shin, JH. Lim, JH. Ahn, I. Choi, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To identify the determinants of the exercise behavior in PD patients Background: The exercise is promising treatment for Parkinson’s disease (PD) which has been…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley